Toto Lisa, Ares Ignacio, Quarta Alberto, Viggiano Pasquale, Ruggeri Marialudovica, Formenti Federico, Boscia Giacomo, Porreca Annamaria, Di Nicola Marta, Boscia Francesco, Mastropasqua Rodolfo
Department of Medicine and Science of Ageing, Ophthalmology Clinic, University G. D'Annunzio Chieti-Pescara, Viale Abruzzo, 322, 66100, Chieti, CH, Italy.
Department of Ophthalmological Research Science, Potsdamer Augenklinik im Albrecht-von-Graefe-Haus GmbH, Hans-Thoma-Straße 11/2, 14467, Potsdam, OG, Germany.
Graefes Arch Clin Exp Ophthalmol. 2025 Feb;263(2):405-414. doi: 10.1007/s00417-024-06666-9. Epub 2024 Oct 19.
To compare the visual and anatomical results of navigated subthreshold micropulse laser (nSML) and photodynamic therapy (PDT) in the treatment of chronic central serous chorioretinopathy (CSCR).
Patients who underwent either half-dose PDT or nSML for the management of chronic CSCR were included in this study. Comprehensive ophthalmic examination, fundus autofluorescence, and spectral domain optical coherence tomography (SD-OCT) were performed at baseline and at 1-, 3-, and 6-month follow-up visits after nSML or PDT. Fluorescein angiography and indocyanine green angiography were performed only at baseline. Main outcome measures were best corrected visual acuity (BCVA), central macular thickness (CMT), subretinal fluid (SRF), subfoveal choroidal thickness (SFCT), and choroidal vascularization index (CVI) that were collected at baseline and at each follow-up visit for up to 6 months.
Forty-two eyes of 42 patients (PDT group-20 eyes, nSML group-22 eyes) affected by chronic CSCR were enrolled. At 6-month follow-up, no significant differences were observed between the nSML group compared to the PDT group in BCVA (0.10 [0.00; 0.20]) and 0.10 [0.10; 0.10], respectively, p=0.69, and between some OCT parameters, namely CMT and CVI. SFCT was significantly reduced in the PDT group more than in the nSML group (p=0.01). Twelve eyes (60%) in the PDT group had complete resolution of the SRF at 6 months compared to 8 eyes (36.4%) in the nSML group, but the difference was not statistically significant (p=0.14).
Results from patients treated with PDT and nSML showed that, at 6 months, no significant differences except for choroidal thickness. nSML is less invasive than PDT and can be used as an effective alternative to PDT.
WHAT IS KNOWN : Treating chronic CSCR is a therapeutic conundrum for clinicians because of a lack of definitive consensus over remediation options, two of which are photodynamic therapy (PDT) and navigated subthreshold micropulse laser (nSML) therapy.
Results from patients treated with PDT and nSML showed no significant differences except for choroidal thickness. Even though patients treated with PDT recovered more quickly, retreatment was necessary due to fluid recollection. Although patients treated with nSML also needed retreatment, nSML is less invasive than PDT and can be used as an effective alternative to PDT.
比较导航阈下微脉冲激光(nSML)和光动力疗法(PDT)治疗慢性中心性浆液性脉络膜视网膜病变(CSCR)的视觉和解剖学结果。
本研究纳入了接受半剂量PDT或nSML治疗慢性CSCR的患者。在基线以及nSML或PDT治疗后的1个月、3个月和6个月随访时进行全面的眼科检查、眼底自发荧光和光谱域光学相干断层扫描(SD-OCT)。仅在基线时进行荧光素血管造影和吲哚菁绿血管造影。主要观察指标为最佳矫正视力(BCVA)、中心黄斑厚度(CMT)、视网膜下液(SRF)、黄斑中心凹下脉络膜厚度(SFCT)和脉络膜血管化指数(CVI),在基线及每次随访直至6个月时收集这些指标。
纳入了42例患者的42只眼(PDT组20只眼,nSML组22只眼)患有慢性CSCR。在6个月随访时,nSML组与PDT组相比,BCVA(分别为0.10 [0.00; 0.20]和0.10 [0.10; 0.10])以及一些OCT参数(即CMT和CVI)之间未观察到显著差异。PDT组的SFCT较nSML组显著降低(p = 0.01)。PDT组12只眼(60%)在6个月时SRF完全消退,而nSML组为8只眼(36.4%),但差异无统计学意义(p = 0.14)。
接受PDT和nSML治疗的患者结果显示,在6个月时,除脉络膜厚度外无显著差异。nSML的侵入性低于PDT,可作为PDT的有效替代方法。
已知信息:由于对治疗方案缺乏明确共识,治疗慢性CSCR对临床医生来说是一个治疗难题,其中两种治疗方法是光动力疗法(PDT)和导航阈下微脉冲激光(nSML)疗法。
接受PDT和nSML治疗的患者结果显示,除脉络膜厚度外无显著差异。尽管接受PDT治疗的患者恢复更快,但由于液体再积聚需要再次治疗。尽管接受nSML治疗的患者也需要再次治疗,但nSML的侵入性低于PDT,可作为PDT的有效替代方法。